​
​

Vivani Medical Stock (NASDAQ:VANI)

RevenueOwnershipFinancialsChart
Vivani Medical by TradingView

Previous Close

$1.25

52W Range

$0.84 - $7.80

50D Avg

$1.22

200D Avg

$1.48

Market Cap

$76.81M

Avg Vol (3M)

$73.40K

Beta

3.52

Div Yield

-

VANI Company Profile

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

36

IPO Date

Nov 19, 2014

Website

VANI Performance

VANI Financial Summary

Dec 23Dec 22Dec 21
Revenue---
Operating Income$-26.96M$-21.24M$-13.32M
Net Income$-25.65M$-6.54M$-12.13M
EBITDA$-26.96M$-27.74M$-13.62M
Basic EPS$-0.50$-0.17$-0.37
Diluted EPS$-0.50$-0.17$-0.37

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q4 19Mar 19, 20 | 5:00 PM
Q3 19Nov 15, 19 | 5:00 PM
Q2 19Aug 07, 19 | 5:00 PM

Peer Comparison

TickerCompany
PMVPPMV Pharmaceuticals, Inc.
TYRATyra Biosciences, Inc.
RLYBRallybio Corporation
TRDAEntrada Therapeutics, Inc.
ANTXAN2 Therapeutics, Inc.
HCWBHCW Biologics Inc.
PHVSPharvaris N.V.
PEPGPepGen Inc.
ANEBAnebulo Pharmaceuticals, Inc.
ELYMEliem Therapeutics, Inc.